12578001: Erythromycin ethylsuccinate (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Antibacterial\Substance with macrolide structure and antibacterial mechanism of action (substance)\Erythromycin ethylsuccinate (substance)

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Anti-infective agent (substance)\Antibacterial\Substance with macrolide structure and antibacterial mechanism of action (substance)\Erythromycin ethylsuccinate (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\Organic compound\Lactone (substance)\Macrolide (substance)\Substance with macrolide structure and antibacterial mechanism of action (substance)\Erythromycin ethylsuccinate (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Erythromycin ethylsuccinate (substance)	Is a	Product containing erythromycin (medicinal product)	false	Inferred relationship	Some
Erythromycin ethylsuccinate (substance)	Is a	Erythromycin (substance)	false	Inferred relationship	Some
Erythromycin ethylsuccinate (substance)	Is a	Substance with macrolide structure and antibacterial mechanism of action (substance)	true	Inferred relationship	Some
Erythromycin ethylsuccinate (substance)	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	Erythromycin (substance)	true	Inferred relationship	Some
Erythromycin ethylsuccinate (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Antibacterial (disposition)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Erythromycin ethyl succinate 200 mg chewable tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Erythromycin ethylsuccinate (substance)	Inferred relationship	Some
Erythromycin ethylsuccinate 100 mg/2.5mL	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Erythromycin ethylsuccinate (substance)	Inferred relationship	Some
Product containing precisely erythromycin ethylsuccinate 400 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Erythromycin ethylsuccinate (substance)	Inferred relationship	Some
Erythromycin ethylsuccinate 400mg/5mL powder	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Erythromycin ethylsuccinate (substance)	Inferred relationship	Some
Erythromycin ethylsuccinate 200mg/5mL suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Erythromycin ethylsuccinate (substance)	Inferred relationship	Some
Erythromycin ethylsuccinate 100mg/2.5mL suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Erythromycin ethylsuccinate (substance)	Inferred relationship	Some
Erythromycin ethylsuccinate 400mg/5mL suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Erythromycin ethylsuccinate (substance)	Inferred relationship	Some
Erythromycin ethylsuccinate + sulfisoxazole acetyl 200mg/600mg oral suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Erythromycin ethylsuccinate (substance)	Inferred relationship	Some
Product containing erythromycin ethylsuccinate and sulfafurazole acetyl	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Erythromycin ethylsuccinate (substance)	Inferred relationship	Some
Product containing erythromycin ethylsuccinate	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Erythromycin ethylsuccinate (substance)	Inferred relationship	Some
Product containing precisely erythromycin ethylsuccinate 400 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Erythromycin ethylsuccinate (substance)	Inferred relationship	Some	1
Product containing precisely erythromycin ethylsuccinate 400 milligram/1 each conventional release oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Erythromycin ethylsuccinate (substance)	Inferred relationship	Some	1
Product containing precisely erythromycin ethylsuccinate 400 milligram/1 each conventional release oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Erythromycin ethylsuccinate (substance)	Inferred relationship	Some	1
Product containing precisely erythromycin (as erythromycin ethylsuccinate) 100 milligram/1 milliliter conventional release oral suspension (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Erythromycin ethylsuccinate (substance)	Inferred relationship	Some	1
Product containing precisely erythromycin (as erythromycin ethylsuccinate) 25 milligram/1 milliliter conventional release oral suspension (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Erythromycin ethylsuccinate (substance)	Inferred relationship	Some	1
Product containing precisely erythromycin (as erythromycin ethylsuccinate) 50 milligram/1 milliliter conventional release oral suspension (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Erythromycin ethylsuccinate (substance)	Inferred relationship	Some	1
Erythromycin ethyl succinate 200 mg chewable tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Erythromycin ethylsuccinate (substance)	Inferred relationship	Some	1
Erythromycin ethyl succinate 200 mg chewable tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Erythromycin ethylsuccinate (substance)	Inferred relationship	Some	1
Product containing precisely erythromycin (as erythromycin ethylsuccinate) 40 milligram/1 milliliter conventional release oral suspension (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Erythromycin ethylsuccinate (substance)	Inferred relationship	Some	1
Product containing precisely erythromycin (as erythromycin ethylsuccinate) 80 milligram/1 milliliter conventional release oral suspension (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Erythromycin ethylsuccinate (substance)	Inferred relationship	Some	1
Erythromycin (as erythromycin ethyl succinate) 400 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Erythromycin ethylsuccinate (substance)	Inferred relationship	Some	1

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
21620019	Erythromycin ethylsuccinate	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
729651015	Erythromycin ethylsuccinate (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
2691868015	Erythromycin ethyl succinate	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
20281000188119	érythromycine éthylsuccinate	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
809461000172111	éthylsuccinate d'érythromycine	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module